Ann: Appendix 4E and Annual Report to Shareholders, page-13

Mate, I will be staying in. I've been invested in this company since the IPO having almost insider insight from my own ATI treatment. They will get there. They are on the verge of a host of announcements. Its just been such a disappointing journey for long-term investors, many of whom understandably bailed.

Management have shown themselves to be disappointing over the last seven years, but they are still a company with excellent treatments and products that are already FDA/EMA/TGA approved and on the verge of mroe approvals and commercial success. Just 2 or 3 years later than they should have been for us long term investors.